Increased adverse events following third dose of BNT162b2/Pfizer vaccine in those with previous COVID-19, but not with concurrent influenza vaccine

Prior studies suggest that adverse events (AEs) following doses one and two of BNT162b2/Pfizer vaccine are worse in those with a prior history of COVID-19. To establish whether this outcome applies to a third/booster dose, we conducted a survey with 534 healthcare workers (HCW) in Northeast England,...

Descripción completa

Detalles Bibliográficos
Autores principales: Raw, Rachael K., Rees, Jon, Chadwick, David R.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Public Library of Science 2023
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10021629/
https://www.ncbi.nlm.nih.gov/pubmed/36963011
http://dx.doi.org/10.1371/journal.pgph.0001053

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10021629/
https://www.ncbi.nlm.nih.gov/pubmed/36963011
http://dx.doi.org/10.1371/journal.pgph.0001053

Ejemplares similares